Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arena Pharmaceuticals Inc (ARNA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arena Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1080709.
Total stock buying since 2014: $252,442.
Total stock sales since 2014: $51,408,800.
Total stock option exercises since 2014: $15,136,843.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2021 | 3,000 | $151,515 | 154,951 | $11,978,638 | 216,724 | $3,046,602 |
2020 | 10 | $677 | 428,785 | $27,316,891 | 434,706 | $7,399,611 |
2019 | 0 | $0 | 142,526 | $7,053,743 | 169,730 | $2,619,373 |
2018 | 0 | $0 | 59,006 | $2,104,178 | 59,006 | $1,065,008 |
2017 | 75,000 | $100,250 | 0 | $0 | 0 | $0 |
2016 | 0 | $0 | 18,728 | $37,306 | 0 | $0 |
2015 | 0 | $0 | 241,268 | $1,248,490 | 366,268 | $758,699 |
2014 | 0 | $0 | 275,174 | $1,669,554 | 151,649 | $247,550 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2021-08 | 3,000 | $151,515 | 17,500 | $1,050,350 | 17,500 | $716,625 |
2021-06 | 0 | $0 | 1,223 | $81,158 | 0 | $0 |
2021-03 | 0 | $0 | 0 | $0 | 25,200 | $0 |
2021-02 | 0 | $0 | 20,024 | $1,588,587 | 20,024 | $779,977 |
2021-01 | 0 | $0 | 116,204 | $9,258,543 | 154,000 | $1,550,000 |
2020-12 | 10 | $677 | 10,389 | $711,291 | 0 | $0 |
2020-11 | 0 | $0 | 0 | $0 | 29,500 | $0 |
2020-08 | 0 | $0 | 147,300 | $10,073,540 | 147,300 | $3,052,999 |
2020-07 | 0 | $0 | 13,000 | $884,000 | 13,000 | $341,640 |
2020-06 | 0 | $0 | 126,631 | $8,394,426 | 125,000 | $2,043,325 |
2020-05 | 0 | $0 | 84,800 | $4,767,704 | 84,800 | $1,238,080 |
2020-02 | 0 | $0 | 46,665 | $2,485,930 | 35,106 | $723,567 |
2019-11 | 0 | $0 | 7,475 | $345,337 | 3,046 | $98,995 |
2019-10 | 0 | $0 | 0 | $0 | 45,900 | $0 |
2019-09 | 0 | $0 | 109,084 | $5,540,326 | 99,084 | $2,125,208 |
2019-06 | 0 | $0 | 4,267 | $239,795 | 0 | $0 |
2019-03 | 0 | $0 | 1,200 | $55,183 | 1,200 | $48,120 |
2019-02 | 0 | $0 | 1,500 | $69,150 | 1,500 | $60,150 |
2019-01 | 0 | $0 | 19,000 | $803,952 | 19,000 | $286,900 |
2018-08 | 0 | $0 | 29,005 | $1,052,823 | 29,005 | $524,990 |
2018-04 | 0 | $0 | 30,001 | $1,051,355 | 30,001 | $540,018 |
2017-05 | 25,000 | $29,750 | 0 | $0 | 0 | $0 |
2017-04 | 50,000 | $70,500 | 0 | $0 | 0 | $0 |
2016-06 | 0 | $0 | 18,728 | $37,306 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-08-16 | Munshi Amit (President and CEO) | Buy | 1,000 | 48.19 | 48,190 |
2021-08-12 | Munshi Amit (President and CEO) | Buy | 1,000 | 50.41 | 50,410 |
2021-08-10 | Munshi Amit (President and CEO) | Buy | 1,000 | 52.91 | 52,915 |
2021-08-03 | Lisicki Robert (EVP, Chief Commercial Officer) | Sale | 17,500 | 60.02 | 1,050,350 |
2021-08-03 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 17,500 | 40.95 | 716,625 |
2021-06-15 | Dallas Jayson Donald Alexander | Sale | 1,223 | 66.36 | 81,158 |
2021-03-16 | Stelzer Laurie (EVP & Chief Financial Officer) | Option Ex | 12,600 | .00 | 0 |
2021-03-15 | Schmidt Joan (EVP, General Counsel & Sec) | Option Ex | 12,600 | .00 | 0 |
2021-02-16 | Aurentz Vincent (Executive VP and CBO) | Sale | 2,524 | 85.00 | 214,540 |
2021-02-16 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 2,524 | 25.10 | 63,352 |
2021-02-02 | Lisicki Robert (EVP, Chief Commercial Officer) | Sale | 17,500 | 78.52 | 1,374,047 |
2021-02-02 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 17,500 | 40.95 | 716,625 |
2021-01-19 | Dallas Jayson Donald Alexander (Director) | Sale | 1,327 | 80.50 | 106,823 |
2021-01-19 | Munshi Amit (President and CEO) | Sale | 50,000 | 80.14 | 4,006,750 |
2021-01-19 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 15.50 | 775,000 |
2021-01-15 | Munshi Amit (President and CEO) | Sale | 50,000 | 80.62 | 4,031,100 |
2021-01-15 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 15.50 | 775,000 |
2021-01-12 | Munshi Amit (President and CEO) | Sale | 14,877 | 74.87 | 1,113,870 |
2021-01-07 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 12,600 | .00 | 0 |
2021-01-07 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 18,000 | .00 | 0 |
2021-01-07 | Munshi Amit (President and CEO) | Option Ex | 23,400 | .00 | 0 |
2020-12-11 | Dallas Jayson Donald Alexander (Director) | Buy | 5 | 69.31 | 346 |
2020-12-08 | Dallas Jayson Donald Alexander (Director) | Buy | 5 | 66.25 | 331 |
2020-12-08 | Munshi Amit (President and CEO) | Sale | 6,517 | 70.00 | 456,196 |
2020-12-01 | Lisicki Robert (EVP, Chief Commercial Officer) | Sale | 3,872 | 65.88 | 255,095 |
2020-11-25 | Cabell Christopher (EVP, Head of R&D, and CMO) | Option Ex | 2,500 | .00 | 0 |
2020-11-25 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 6,300 | .00 | 0 |
2020-11-25 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 9,000 | .00 | 0 |
2020-11-25 | Munshi Amit (President and CEO) | Option Ex | 11,700 | .00 | 0 |
2020-08-31 | Munshi Amit (President and CEO) | Sale | 50,000 | 70.10 | 3,505,050 |
2020-08-31 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 15.50 | 775,000 |
2020-08-28 | Munshi Amit (President and CEO) | Sale | 50,000 | 70.00 | 3,500,000 |
2020-08-28 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 15.50 | 775,000 |
2020-08-26 | Nova Tina Susan (Director) | Sale | 17,300 | 67.94 | 1,175,310 |
2020-08-26 | Nova Tina Susan (Director) | Option Ex | 17,300 | 15.87 | 274,499 |
2020-08-04 | Lisicki Robert (EVP, Chief Commercial Officer) | Sale | 30,000 | 63.11 | 1,893,180 |
2020-08-04 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 30,000 | 40.95 | 1,228,500 |
2020-07-15 | Cabell Christopher (EVP, Head of R&D, and CMO) | Sale | 13,000 | 68.00 | 884,000 |
2020-07-15 | Cabell Christopher (EVP, Head of R&D, and CMO) | Option Ex | 13,000 | 26.28 | 341,640 |
2020-06-17 | Soni Manmeet Singh (Director) | Sale | 304 | 62.74 | 19,072 |
2020-06-15 | Soni Manmeet Singh (Director) | Sale | 1,327 | 60.12 | 79,779 |
2020-06-03 | Munshi Amit (President and CEO) | Sale | 50,000 | 68.41 | 3,420,550 |
2020-06-03 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 15.05 | 752,500 |
2020-06-02 | Aurentz Vincent (Executive VP and CBO) | Sale | 25,000 | 65.00 | 1,625,025 |
2020-06-02 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 25,000 | 22.43 | 560,825 |
2020-06-02 | Munshi Amit (President and CEO) | Sale | 50,000 | 65.00 | 3,250,000 |
2020-06-02 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 14.60 | 730,000 |
2020-05-22 | Munshi Amit (President and CEO) | Sale | 34,800 | 57.98 | 2,017,704 |
2020-05-22 | Munshi Amit (President and CEO) | Option Ex | 34,800 | 14.60 | 508,080 |
2020-05-21 | Munshi Amit (President and CEO) | Sale | 50,000 | 55.00 | 2,750,000 |
2020-05-21 | Munshi Amit (President and CEO) | Option Ex | 50,000 | 14.60 | 730,000 |
2020-02-27 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 7,970 | 14.90 | 118,753 |
2020-02-13 | Lind Kevin Robert (Executive VP and CFO) | Sale | 4,500 | 55.00 | 247,500 |
2020-02-13 | Lind Kevin Robert (Executive VP and CFO) | Option Ex | 4,500 | 27.50 | 123,750 |
2020-02-13 | Munshi Amit (President and CEO) | Sale | 15,200 | 55.00 | 836,000 |
2020-02-13 | Munshi Amit (President and CEO) | Option Ex | 15,200 | 14.60 | 221,920 |
2020-02-13 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 10,836 | 55.00 | 595,980 |
2020-02-13 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 7,436 | 34.85 | 259,144 |
2020-02-05 | Aurentz Vincent (Executive VP and CBO) | Sale | 9,000 | 50.00 | 450,000 |
2020-02-05 | Munshi Amit (President and CEO) | Sale | 7,129 | 50.00 | 356,450 |
2019-11-13 | Lisicki Robert (EVP, Chief Commercial Officer) | Sale | 4,429 | 45.83 | 202,998 |
2019-11-12 | Woods Randall E (Director) | Sale | 3,046 | 46.73 | 142,339 |
2019-11-12 | Woods Randall E (Director) | Option Ex | 3,046 | 32.50 | 98,995 |
2019-10-14 | Lisicki Robert (EVP, Chief Commercial Officer) | Option Ex | 6,300 | .00 | 0 |
2019-10-14 | Lind Kevin Robert (Executive VP and CFO) | Option Ex | 6,300 | .00 | 0 |
2019-10-14 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 9,000 | .00 | 0 |
2019-10-14 | Munshi Amit (President and CEO) | Option Ex | 11,700 | .00 | 0 |
2019-10-14 | Klassen Preston (EVP and CMO) | Option Ex | 6,300 | .00 | 0 |
2019-10-14 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 6,300 | .00 | 0 |
2019-09-10 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 12,627 | 50.28 | 634,872 |
2019-09-10 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 12,627 | 15.50 | 195,718 |
2019-09-09 | Aurentz Vincent (Executive VP and CBO) | Sale | 65,000 | 50.86 | 3,305,835 |
2019-09-09 | Aurentz Vincent (Executive VP and CBO) | Option Ex | 65,000 | 22.43 | 1,458,145 |
2019-09-09 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 31,457 | 50.85 | 1,599,619 |
2019-09-09 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 21,457 | 21.97 | 471,345 |
2019-06-14 | Dallas Jayson Donald Alexander (Director) | Sale | 1,525 | 56.16 | 85,648 |
2019-06-14 | Soni Manmeet Singh (Director) | Sale | 1,217 | 56.16 | 68,351 |
2019-06-14 | Fetzer Oliver (Director) | Sale | 1,525 | 56.26 | 85,796 |
2019-03-07 | Nova Tina Susan (Director) | Sale | 1,200 | 45.99 | 55,183 |
2019-03-07 | Nova Tina Susan (Director) | Option Ex | 1,200 | 40.10 | 48,120 |
2019-02-01 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 1,500 | 46.10 | 69,150 |
2019-02-01 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 1,500 | 40.10 | 60,150 |
2019-01-08 | Klassen Preston (EVP and CMO) | Sale | 3,000 | 44.00 | 132,000 |
2019-01-08 | Klassen Preston (EVP and CMO) | Option Ex | 3,000 | 15.10 | 45,300 |
2019-01-07 | Klassen Preston (EVP and CMO) | Sale | 16,000 | 42.00 | 671,952 |
2019-01-07 | Klassen Preston (EVP and CMO) | Option Ex | 16,000 | 15.10 | 241,600 |
2018-08-15 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 29,005 | 36.30 | 1,052,823 |
2018-08-15 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 29,005 | 18.10 | 524,990 |
2018-04-16 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 30,001 | 35.04 | 1,051,355 |
2018-04-16 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 30,001 | 18.00 | 540,018 |
2017-05-12 | Munshi Amit (President and CEO) | Buy | 25,000 | 1.19 | 29,750 |
2017-04-26 | Munshi Amit (President and CEO) | Buy | 50,000 | 1.41 | 70,500 |
2016-06-13 | White Christine Anna (Director) | Sale | 18,728 | 1.99 | 37,306 |
2015-03-30 | Woods Randall E (Director) | Sale | 76,268 | 4.49 | 342,290 |
2015-03-30 | Woods Randall E (Director) | Option Ex | 76,268 | 1.38 | 105,249 |
2015-03-17 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 70,000 | 5.00 | 350,000 |
2015-03-17 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 70,000 | 1.65 | 115,500 |
2015-03-03 | Lief Jack (President and CEO) | Option Ex | 125,000 | 1.49 | 186,250 |
2015-01-08 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 45,000 | 6.26 | 281,700 |
2015-01-08 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 45,000 | 6.16 | 277,200 |
2015-01-07 | Shanahan William R Jr (SVP & Chief Medical Officer) | Sale | 50,000 | 5.49 | 274,500 |
2015-01-07 | Shanahan William R Jr (SVP & Chief Medical Officer) | Option Ex | 50,000 | 1.49 | 74,500 |
2014-09-17 | Lief Jack (Chairman, President and CEO) | Option Ex | 100,000 | 1.49 | 149,000 |
2014-07-01 | Lief Jack (Chairman, President and CEO) | Sale | 223,525 | 5.85 | 1,308,515 |
2014-06-27 | Belcher Donald D (Director) | Sale | 2,473 | 5.85 | 14,467 |
2014-06-27 | Belcher Donald D (Director) | Option Ex | 2,473 | 5.46 | 13,502 |
2014-05-12 | Spector Steven W (EVP, General Counsel & Sec) | Sale | 45,000 | 7.05 | 317,340 |
2014-05-12 | Spector Steven W (EVP, General Counsel & Sec) | Option Ex | 45,000 | 1.49 | 67,050 |
2014-05-06 | Belcher Donald D (Director) | Sale | 4,176 | 7.00 | 29,232 |
2014-05-06 | Belcher Donald D (Director) | Option Ex | 4,176 | 4.31 | 17,998 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arena Pharmaceuticals Inc (symbol ARNA, CIK number 1080709) see the Securities and Exchange Commission (SEC) website.